1. Home
  2. IKT vs HFFG Comparison

IKT vs HFFG Comparison

Compare IKT & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • HFFG
  • Stock Information
  • Founded
  • IKT 2008
  • HFFG N/A
  • Country
  • IKT United States
  • HFFG United States
  • Employees
  • IKT N/A
  • HFFG N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • HFFG Food Distributors
  • Sector
  • IKT Health Care
  • HFFG Consumer Discretionary
  • Exchange
  • IKT Nasdaq
  • HFFG Nasdaq
  • Market Cap
  • IKT 159.2M
  • HFFG 180.3M
  • IPO Year
  • IKT 2020
  • HFFG N/A
  • Fundamental
  • Price
  • IKT $3.05
  • HFFG $3.20
  • Analyst Decision
  • IKT Strong Buy
  • HFFG
  • Analyst Count
  • IKT 2
  • HFFG 0
  • Target Price
  • IKT $6.50
  • HFFG N/A
  • AVG Volume (30 Days)
  • IKT 451.1K
  • HFFG 46.4K
  • Earning Date
  • IKT 11-14-2024
  • HFFG 11-12-2024
  • Dividend Yield
  • IKT N/A
  • HFFG N/A
  • EPS Growth
  • IKT N/A
  • HFFG N/A
  • EPS
  • IKT N/A
  • HFFG N/A
  • Revenue
  • IKT $1.00
  • HFFG $1,177,258,000.00
  • Revenue This Year
  • IKT N/A
  • HFFG $5.18
  • Revenue Next Year
  • IKT N/A
  • HFFG $2.73
  • P/E Ratio
  • IKT N/A
  • HFFG N/A
  • Revenue Growth
  • IKT N/A
  • HFFG 1.53
  • 52 Week Low
  • IKT $1.12
  • HFFG $2.46
  • 52 Week High
  • IKT $4.20
  • HFFG $5.91
  • Technical
  • Relative Strength Index (RSI)
  • IKT 51.80
  • HFFG 34.42
  • Support Level
  • IKT $2.90
  • HFFG $3.20
  • Resistance Level
  • IKT $4.20
  • HFFG $3.79
  • Average True Range (ATR)
  • IKT 0.41
  • HFFG 0.18
  • MACD
  • IKT -0.07
  • HFFG -0.07
  • Stochastic Oscillator
  • IKT 11.54
  • HFFG 0.53

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

Share on Social Networks: